Document ID: chunk:federal_register_of_legislation:F2024L01730:schedule:1:p14
Version: federal_register_of_legislation:F2024L01730
Segment Type: schedule
Provision Reference: sch 1 (pt 14/30)
Character Range: 40365–43446

Tablet 100 mg
omit:
Lamotrigine  Tablet 100 mg  Oral  NOUMED LAMOTRIGINE  VO  MP NP  C11081  P11081  56   5     56
Lamotrigine  Tablet 100 mg  Oral  NOUMED LAMOTRIGINE  VO  MP NP  C14855  P14855  112  5     56

[82] Schedule 1, Part 1, entries for Lamotrigine in the form Tablet 200 mg
omit:
Lamotrigine  Tablet 200 mg  Oral  NOUMED LAMOTRIGINE  VO  MP NP  C11081  P11081  56   5     56
Lamotrigine  Tablet 200 mg  Oral  NOUMED LAMOTRIGINE  VO  MP NP  C14855  P14855  112  5     56

[83] Schedule 1, Part 1, entries for Lansoprazole in the form Capsule 30 mg
omit:
Lansoprazole  Capsule 30 mg  Oral  NOUMED LANSOPRAZOLE  VO  MP NP  C8774 C8775           P8774 P8775           28   1     28
Lansoprazole  Capsule 30 mg  Oral  NOUMED LANSOPRAZOLE  VO  MP NP  C8776 C8780           P8776 P8780           28   5     28
Lansoprazole  Capsule 30 mg  Oral  NOUMED LANSOPRAZOLE  VO  MP NP  C11310 C15530 C15658  P11310 P15530 P15658  56   5     28
Lansoprazole  Capsule 30 mg  Oral  NOUMED LANSOPRAZOLE  VO  MP     C15856                P15856                112  5     28

[84] Schedule 1, Part 1, entry for Liothyronine [Maximum Quantity: 200; Number of Repeats: 2]
(a) omit from the column headed "Circumstances": C15038
(b) omit from the column headed "Purposes": P15038
[85] Schedule 1, Part 1, entries for Metformin in the form Tablet containing metformin hydrochloride 500 mg [Brand: APX-Metformin]
omit from the column headed "Brand": APX-Metformin substitute: APX-METFORMIN
[86] Schedule 1, Part 1, entries for Metformin in the form Tablet containing metformin hydrochloride 850 mg [Brand: APX-Metformin]
omit from the column headed "Brand": APX-Metformin substitute: APX-METFORMIN
[87] Schedule 1, Part 1, entries for Metformin in the form Tablet containing metformin hydrochloride 1 g [Brand: APX-Metformin]
omit from the column headed "Brand": APX-Metformin substitute: APX-METFORMIN
[88] Schedule 1, Part 1, entries for Metoprolol in the form Tablet containing metoprolol tartrate 50 mg
omit:
Metoprolol  Tablet containing metoprolol tartrate 50 mg  Oral  NOUMED METOPROLOL  VO  MP NP             100  5     100
Metoprolol  Tablet containing metoprolol tartrate 50 mg  Oral  NOUMED METOPROLOL  VO  MP NP     P14238  200  5     100

[89] Schedule 1, Part 1, entries for Metoprolol in the form Tablet containing metoprolol tartrate 100 mg
omit:
Metoprolol  Tablet containing metoprolol tartrate 100 mg  Oral  NOUMED METOPROLOL  VO  MP NP             60   5     60
Metoprolol  Tablet containing metoprolol tartrate 100 mg  Oral  NOUMED METOPROLOL  VO  MP NP     P14238  120  5     60

[90] Schedule 1, Part 1, entries for Mycophenolic acid in the form Capsule containing mycophenolate mofetil 250 mg
omit:
Mycophenolic acid  Capsule containing mycophenolate mofetil 250 mg  Oral  Ceptolate  AF  MP             300  5     50
Mycophenolic acid  Capsule containing mycophenolate mofetil 250 mg  Oral  Ceptolate  AF  MP     P14238  600  5     50

[91] Schedule 1, Part 1, entries for Nivolumab
insert in the column headed "Variations" (all instances): V15527
[92] Schedule 1, Part 1,